The human gut phage community and its implications for health and disease

Viruses

Volumn 9, Issue 6, 2017, Pages

  Manrique, Pilar ^a   Dills, Michael ^a   Young, Mark J ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

Gut microbiome bacteriophages; Gut microbiome phages; Gut prophage reservoir; Healthy gut phages

Indexed keywords

BACTERIAL GROWTH; BACTERIOPHAGE; DYSBIOSIS; ECOSYSTEM RESILIENCE; GENETIC VARIABILITY; HOST PARASITE INTERACTION; HUMAN; LYSOGENIZATION; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BACTERIUM; GASTROINTESTINAL TRACT; GENETICS; INTESTINE FLORA; METAGENOME; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPHAGE; VIROLOGY;

ANIMALS; BACTERIA; BACTERIOPHAGES; DYSBIOSIS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; LYSOGENY; METAGENOME; MICE; PROPHAGES;

EID: 85020737732     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v9060141     Document Type: Review

References (130)

1. Lloyd-Price J., Abu-Ali G., Huttenhower, C. The healthy human microbiome. Genome Med. 2016, 8, 51.
2. Faith, J.J.; Guruge, J.L.; Charbonneau, M.; Subramanian, S.; Seedorf, H.; Goodman, A.L.; Clemente, J.C.; Knight, R.; Heath, A.C.; Leibel, R.L., et al. The long‐term stability of the human gut microbiota. Science 2013, 341, 1237439.
3. Backhed, F.; Fraser, C.M.; Ringel, Y.; Sanders, M.E.; Sartor, R.B.; Sherman, P.M.; Versalovic, J.; Young, V.; Finlay, B.B. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012, 12, 611–622.
4. Dethlefsen, L.; Huse, S.; Sogin, M.L.; Relman, D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008, 6, e280.
5. Relman, D.A. The human microbiome: ecosystem resilience and health. Nutr. Rev. 2012, 70, S2–S9.
6. Human Microbiome Project. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486, 207–214.
7. Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 597–65.
8. Turnbaugh, P.J.; Hamady, M.; Yatsunenko, T.; Cantarel, B.L.; Duncan, A.; Ley, R.E.; Sogin, M.L.; Jones, W. J.; Roe, B.A.; Affourtit, J.P., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457, 480–484.
9. Peterson, D.A.; Frank, D.N.; Pace, N.R.; Gordon, J.I. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008, 3, 417–427.
10. Clemente, J.C.; Ursell, L.K.; Parfrey, L.W.; Knight, R. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148, 1258–1270.
11. Norman, J.M.; Handley, S.A.; Baldridge, M.T.; Droit, L.; Liu, C.Y.; Keller, B.C.; Kambal, A.; Monaco, C.L.; Zhao, G.; Fleshner, P., et al. Disease‐specific alterations in the enteric virome in inflammatory bowel disease. Cell 2015, 160, 447–460.
12. Sulakvelidze, A. Phage therapy: an attractive option for dealing with antibiotic‐resistant bacterial infections. Drug Discov. Today 2005, 10, 807–809.
13. Brussow, H.; Canchaya, C.; Hardt, W.D. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol. Mol. Biol. Rev. 2004, 68, 560–602.
14. Wagner, P.L.; Waldor, M.K., Bacteriophage control of bacterial virulence. Infect. Immun. 2002, 70, 3985–3993.
15. Fuhrman, J. A. Marine viruses and their biogeochemical and ecological effects. Nature 1999, 399, 541–548.
16. Reyes, A.; Semenkovich, N.P.; Whiteson, K.; Rohwer, F.; Gordon, J.I., Going viral: next‐generation sequencing applied to phage populations in the human gut. Nat. Rev. Microbiol. 2012, 10, 607–617.
17. De Paepe, M.; Leclerc, M.; Tinsley, C.R.; Petit, M.A. Bacteriophages: an underestimated role in human and animal health? Front. Cell Infect. Microbiol. 2014, 4, 39.
18. Mills, S.; Shanahan, F.; Stanton, C.; Hill, C.; Coffey, A.; Ross, R.P. Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes 2013, 4, 4–16.
19. Ogilvie, L.A.; Jones, B.V. The human gut virome: a multifaceted majority. Front. Microbiol. 2015, 6, 918.
20. Dalmasso, M.; Hill, C.; Ross, R.P. Exploiting gut bacteriophages for human health. Trends Microbiol. 2014, 22, 399–405.
21. Zeng, L.; Skinner, S.O.; Zong, C.; Sippy, J.; Feiss, M.; Golding, I. Decision making at a subcellular level determines the outcome of bacteriophage infection. Cell 2010, 141, 682–691.
22. Los, M.; Wegrzyn, G. Pseudolysogeny. Adv. Virus. Res. 2012, 82, 339–349.
23. Cenens, W.; Makumi, A.; Govers, S.K.; Lavigne, R.; Aertsen, A. Viral Transmission Dynamics at Single‐Cell Resolution Reveal Transiently Immune Subpopulations Caused by a Carrier State Association. PLoS Genet. 2015, 11, e1005770.
24. Kai, M.; Watanabe, S.; Furuse, K.; Ozawa, A. Bacteroides bacteriophages isolated from human feces. Microbiol. Immunol. 1985, 29, 895–899.
25. Maura, D.; Debarbieux, L. On the interactions between virulent bacteriophages and bacteria in the gut. Bacteriophage 2012, 2, 229–233.
26. Smeal, S.W.; Schmitt, M.A.; Pereira, R.R.; Prasad, A.; Fisk, J.D. Simulation of the M13 life cycle I: Assembly of a genetically‐structured deterministic chemical kinetic simulation. Virology 2017, 500, 259–274.
27. Rodriguez-Valera F.; Martin-Cuadrado A.B.; Rodriguez-Brito B.; Pasic, L.; Thingstad, T.F.; Rohwer, F.; Mira, A. Explaining microbial population genomics through phage predation. Nat. Rev. Microbiol. 2009, 7, 828–836.
28. Brum, J.R.; Sullivan, M.B. Rising to the challenge: accelerated pace of discovery transforms marine virology. Nat. Rev. Microbiol. 2015, 13, 147–159.
29. Pal, C.; Macia, M.D.; Oliver, A.; Schachar, I.; Buckling, A. Coevolution with viruses drives the evolution of bacterial mutation rates. Nature 2007, 450, 1079–1081.
30. Scanlan, P.D.; Hall, A.R.; Blackshields, G.; Friman, V.P.; Davis, M.R., Jr.; Goldberg, J.B.; Buckling, A. Coevolution with bacteriophages drives genome‐wide host evolution and constrains the acquisition of abiotic‐beneficial mutations. Mol. Biol. Evol. 2015, 32, 1425–1435.
31. Scanlan, P.D. Bacteria‐Bacteriophage Coevolution in the Human Gut: Implications for Microbial Diversity and Functionality. Trends Microbiol. 2017, doi: 10.1016/j.tim.2017.02.012.
32. Lotka, A.J. Fluctuations in the abundance of a species considered mathematically. Nature 1927, 119, 12.
33. Volterra, V. Fluctuations in the abundance of a species considered mathematically. Nature 1926, 118, 558–560.
34. Williams, H.T. Phage‐induced diversification improves host evolvability. BMC Evol. Biol. 2013, 13, 17.
35. Paul, J.H. Prophages in marine bacteria: dangerous molecular time bombs or the key to survival in the seas? ISME J 2008, 2, 579–589.
36. Breitbart, M. Marine viruses: truth or dare. Ann. Rev. Mar. Sci. 2012, 4, 425–448.
37. Jiang, S.C.; Paul, J.H. Gene transfer by transduction in the marine environment. Appl. Environ. Microbiol. 1998, 64, 2780–2787.
38. Rodriguez-Brito B.; Li, L.; Wegley, L.; Furlan, M.; Angly, F.; Breitbart, M.; Buchanan, J.; Desnues, C.; Dinsdale, E.; Edwards, R., et al. Viral and microbial community dynamics in four aquatic environments. ISME J 2010, 4, 739–751.
39. Modi, S.R.; Lee, H.H.; Spina, C.S.; Collins, J.J. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 2013, 499, 219–222.
40. Brum, J.R.; Hurwitz, B.L.; Schofield, O.; Ducklow, H.W.; Sullivan, M.B. Seasonal time bombs: dominant temperate viruses affect Southern Ocean microbial dynamics. ISME J. 2016, 10, 437–449.
41. Knowles, B.; Silveira, C.B.; Bailey, B.A.; Barott, K.; Cantu, V.A.; Cobian-Guemes A.G.; Coutinho, F.H.; Dinsdale, E.A.; Felts, B.; Furby, K.A.; et al. Lytic to temperate switching of viral communities. Nature 2016, 531, 466–470.
42. Cadwell, K. The virome in host health and disease. Immunity 2015, 42, 805–813.
43. Cadwell, K. Expanding the role of the virome: commensalism in the gut. J. Virol. 2015, 89, 1951–1953.
44. Mokili, J.L.; Rohwer, F.; Dutilh, B.E. Metagenomics and future perspectives in virus discovery. Curr. Opin. Virol. 2012, 2, 63–77.
45. Wylie, K.M.; Mihindukulasuriya, K.A.; Zhou, Y.; Sodergren, E.; Storch, G.A.; Weinstock, G.M. Metagenomic analysis of double‐stranded DNA viruses in healthy adults. BMC Biol. 2014, 12, 71.
46. Robinson, C.M.; Pfeiffer, J.K. Viruses and the Microbiota. Annu. Rev. Virol. 2014, 1, 55–69.
47. Duerkop, B.A.; Hooper, L.V. Resident viruses and their interactions with the immune system. Nat. Immunol. 2013, 14, 654–659.
48. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P., et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222–227.
49. O’Toole, P.W.; Jeffery, I.B. Gut microbiota and aging. Science 2015, 350, 1214–1215.
50. Breitbart, M.; Haynes, M.; Kelley, S.; Angly, F.; Edwards, R. A.; Felts, B.; Mahaffy, J. M.; Mueller, J.; Nulton, J.; Rayhawk, S., et al., Viral diversity and dynamics in an infant gut. Res. Microbiol. 2008, 159, 367-73.
51. Lim, E.S.; Zhou, Y.; Zhao, G.; Bauer, I.K.; Droit, L.; Ndao, I.M.; Warner, B.B.; Tarr, P.I.; Wang, D.; Holtz, L.R. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat. Med. 2015, 21, 1228–1234.
52. Reyes, A.; Blanton, L.V.; Cao, S.; Zhao, G.; Manary, M.; Trehan, I.; Smith, M.I.; Wang, D.; Virgin, H.W.; Rohwer, F.; et al. Gut DNA viromes of Malawian twins discordant for severe acute malnutrition. Proc. Natl. Acad. Sci. USA 2015, 112, 11941–11946.
53. Morowitz, M.J.; Denef, V.J.; Costello, E.K.; Thomas, B.C.; Poroyko, V.; Relman, D.A.; Banfield, J.F. Strainresolved community genomic analysis of gut microbial colonization in a premature infant. Proc. Natl. Acad. Sci. USA 2011, 108, 1128–1133.
54. Sharon, I.; Morowitz, M.J.; Thomas, B.C.; Costello, E.K.; Relman, D.A.; Banfield, J.F. Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization. Genome. Res. 2013, 23, 111–120.
55. Lugli, G.A.; Milani, C.; Turroni, F.; Tremblay, D.; Ferrario, C.; Mancabelli, L.; Duranti, S.; Ward, D.V.; Ossiprandi, M.C.; Moineau, S., et al. Prophages of the genus Bifidobacterium as modulating agents of the infant gut microbiota. Environ. Microbiol. 2016, 18, 2196–2213.
56. Castro-Mejia, J.L.; Muhammed, M.K.; Kot, W.; Neve, H.; Franz, C.M.; Hansen, L.H.; Vogensen, F.K.; Nielsen, D.S. Optimizing protocols for extraction of bacteriophages prior to metagenomic analyses of phage communities in the human gut. Microbiome 2015, 3, 64.
57. Hoyles, L.; McCartney, A.L.; Neve, H.; Gibson, G.R.; Sanderson, J.D.; Heller, K.J.; van Sinderen, D. Characterization of virus‐like particles associated with the human faecal and caecal microbiota. Res. Microbiol. 2014, 165, 803–812.
58. Barr, J.J.; Auro, R.; Furlan, M.; Whiteson, K.L.; Erb, M.L.; Pogliano, J.; Stotland, A.; Wolkowicz, R.; Cutting, A.S.; Doran, K.S.; et al. Bacteriophage adhering to mucus provide a non‐host‐derived immunity. Proc. Natl. Acad. Sci. USA 2013, 110, 10771–10776.
59. Maura, D.; Galtier, M.; Le Bouguenec, C.; Debarbieux, L. Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine. Antimicrob. Agents Chemother. 2012, 56, 6235–6242.
60. Furuse, K.; Osawa, S.; Kawashiro, J.; Tanaka, R.; Ozawa, A.; Sawamura, S.; Yanagawa, Y.; Nagao, T.; Watanabe, I. Bacteriophage distribution in human faeces: continuous survey of healthy subjects and patients with internal and leukaemic diseases. J. Gen. Virol. 1983, 64, 2039–2043.
61. Reyes, A.; Haynes, M.; Hanson, N.; Angly, F.E.; Heath, A.C.; Rohwer, F.; Gordon, J.I. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010, 466, 334–338.
62. Minot, S.; Sinha, R.; Chen, J.; Li, H.; Keilbaugh, S.A.; Wu, G.D.; Lewis, J.D.; Bushman, F.D. The human gut virome: inter‐individual variation and dynamic response to diet. Genome Res. 2011, 21, 1616–1625.
63. Minot, S.; Bryson, A.; Chehoud, C.; Wu, G.D.; Lewis, J.D.; Bushman, F.D. Rapid evolution of the human gut virome. Proc. Natl. Acad. Sci. USA 2013, 110, 12450–12455.
64. Manrique, P.; Bolduc, B.; Walk, S.T.; van der Oost, J.; de Vos, W.M.; Young, M.J. Healthy human gut phageome. Proc. Natl. Acad. Sci. USA 2016, 113, 10400–10405.
65. Zhang, T.; Breitbart, M.; Lee, W.H.; Run, J.Q.; Wei, C.L.; Soh, S.W.; Hibberd, M.L.; Liu, E.T.; Rohwer, F.; Ruan, Y. RNA viral community in human feces: prevalence of plant pathogenic viruses. PLoS Biol. 2006, 4, e3.
66. Krishnamurthy, S.R.; Janowski, A.B.; Zhao, G.; Barouch, D.; Wang, D. Hyperexpansion of RNA Bacteriophage Diversity. PLoS Biol. 2016, 14, e1002409.
67. Havelaar, A.H.; Furuse, K.; Hogeboom, W.M. Bacteriophages and indicator bacteria in human and animal faeces. J. Appl. Bacteriol. 1986, 60, 255–262.
68. Bolduc, B.; Wirth, J.F.; Mazurie, A.; Young, M.J. Viral assemblage composition in Yellowstone acidic hot springs assessed by network analysis. ISME J. 2015, 9, 2162–2177.
69. Lima-Mendez, G.; Van Helden, J.; Toussaint, A.; Leplae, R. Reticulate representation of evolutionary and functional relationships between phage genomes. Mol. Biol. Evol. 2008, 25, 762–777.
70. Roux, S.; Enault, F.; Hurwitz, B.L.; Sullivan, M.B. VirSorter: mining viral signal from microbial genomic data. PeerJ. 2015, 3, e985.
71. Roux, S.; Hallam, S.J.; Woyke, T.; Sullivan, M.B. Viral dark matter and virus‐host interactions resolved from publicly available microbial genomes. Elife 2015, 4, e08490.
72. Santiago-Rodriguez, T.M.; Ly, M.; Bonilla, N.; Pride, D.T. The human urine virome in association with urinary tract infections. Front. Microbiol. 2015, 6, 14.
73. Angly, F.; Rodriguez-Brito B.; Bangor, D.; McNairnie, P.; Breitbart, M.; Salamon, P.; Felts, B.; Nulton, J.; Mahaffy, J.; Rohwer, F. PHACCS, an online tool for estimating the structure and diversity of uncultured viral communities using metagenomic information. BMC Bioinformatics 2005, 6, 41.
74. Ignacio-Espinoza, J.C.; Solonenko, S.A.; Sullivan, M.B. The global virome: not as big as we thought? Cur.r Opin. Virol. 2013, 3, 566–771.
75. Roux, S.; Tournayre, J.; Mahul, A.; Debroas, D.; Enault, F, Metavir 2: new tools for viral metagenome comparison and assembled virome analysis. BMC Bioinformatics 2014, 15, 76.
76. Wommack, K.E.; Bhavsar, J.; Polson, S.W.; Chen, J.; Dumas, M.; Srinivasiah, S.; Furman, M.; Jamindar, S.; Nasko, D.J. VIROME: a standard operating procedure for analysis of viral metagenome sequences. Stand Genomic Sci. 2012, 6, 427–439.
77. Huson, D.H.; Beier, S.; Flade, I.; Gorska, A.; El-Hadidi, M.; Mitra, S.; Ruscheweyh, H.J.; Tappu, R. MEGAN Community Edition ‐ Interactive Exploration and Analysis of Large‐Scale Microbiome Sequencing Data. PLoS Comput. Biol. 2016, 12, e1004957.
78. Waller, A.S.; Yamada, T.; Kristensen, D.M.; Kultima, J.R.; Sunagawa, S.; Koonin, E.V.; Bork, P. Classification and quantification of bacteriophage taxa in human gut metagenomes. ISME J. 2014, 8, 1391–1402.
79. Kim, M.S.; Park, E.J.; Roh, S.W.; Bae, J.W. Diversity and abundance of single‐stranded DNA viruses in human feces. Appl. Environ. Microbiol. 2011, 77, 8062–8070.
80. Roux, S.; Krupovic, M.; Poulet, A.; Debroas, D.; Enault, F. Evolution and diversity of the Microviridae viral family through a collection of 81 new complete genomes assembled from virome reads. PLoS One 2012, 7, e40418.
81. Krupovic, M.; Forterre, P. Microviridae goes temperate: microvirus‐related proviruses reside in the genomes of Bacteroidetes. PLoS One 2011, 6, e19893.
82. Paez-Espino, D.; Eloe-Fadrosh, E.A.; Pavlopoulos, G.A.; Thomas, A.D.; Huntemann, M.; Mikhailova, N.; Rubin, E.; Ivanova, N.N.; Kyrpides, N.C. Uncovering Earthʹs virome. Nature 2016, 536, 425–430.
83. Dutilh, B.E.; Cassman, N.; McNair, K.; Sanchez, S.E.; Silva, G.G.; Boling, L.; Barr, J.J.; Speth, D.R.; Seguritan, V.; Aziz, R.K.; et al. A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes. Nat. Commun. 2014, 5, 4498.
84. Ogilvie, L.A.; Bowler, L.D.; Caplin, J.; Dedi, C.; Diston, D.; Cheek, E.; Taylor, H.; Ebdon, J.E.; Jones, B.V. Genome signature‐based dissection of human gut metagenomes to extract subliminal viral sequences. Nat. Commun. 2013, 4, 2420.
85. Stern, A.; Mick, E.; Tirosh, I.; Sagy, O.; Sorek, R. CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome. Genome Research 2012, 22, 1985–1994.
86. Robles-Sikisaka, R.; Ly, M.; Boehm, T.; Naidu, M.; Salzman, J.; Pride, D.T. Association between living environment and human oral viral ecology. ISME J. 2013, 7, 1710–1724.
87. Ly, M.; Jones, M.B.; Abeles, S.R.; Santiago-Rodriguez, T.M.; Gao, J.; Chan, I.C.; Ghose, C.; Pride, D.T. Transmission of viruses via our microbiomes. Microbiome 2016, 4, 64.
88. Lepage, P.; Colombet, J.; Marteau, P.; Sime-Ngando, T.; Dore, J.; Leclerc, M. Dysbiosis in inflammatory bowel disease: a role for bacteriophages? Gut 2008, 57, 424–425.
89. Kim, M.S.; Bae, J.W. Spatial disturbances in altered mucosal and luminal gut viromes of diet‐induced obese mice. Environ. Microbiol. 2016, 18, 1498–1510.
90. Silveira, C.B; Rowler, F.L. Piggy‐back‐the‐Winner in host‐associated microbial communities. Biofilms and Microbiomes 2016, 18, 1498–1510.
91. Weitz, J.; Beckett, S.J.; Brum, J.R.; Cael, B.B.; Dushoff, J. Lysis, Lysogeny, and Virus‐Microbe Ratios. Biorxiv 2016, doi:10.1101/051805.
92. Erez, Z.; Steinberger-Levy, I.; Shamir, M.; Doron, S.; Stokar-Avihail, A.; Peleg, Y.; Melamed, S.; Leavitt, A.; Savidor, A.; Albeck, S., et al. Communication between viruses guides lysis‐lysogeny decisions. Nature 2017, 541, 488–493.
93. Mirzaei, M.K.; Maurice, C.F. Menage a trois in the human gut: interactions between host, bacteria and phages. Nat. Rev. Microbiol. 2017. doi:10.1038/nrmicro.2017.30.
94. Labrie, S.J.; Samson, J.E.; Moineau, S. Bacteriophage resistance mechanisms. Nat. Rev. Microbiol. 2010, 8, 317–327.
95. Goldberg, G.W.; Jiang, W.; Bikard, D.; Marraffini, L.A. Conditional tolerance of temperate phages via transcription‐dependent CRISPR‐Cas targeting. Nature 2014, 514, 633–637.
96. Sorek, R.; Lawrence, C.M.; Wiedenheft, B. CRISPR‐mediated adaptive immune systems in bacteria and archaea. Annu. Rev. Biochem. 2013, 82, 237–266.
97. Mick, E.; Stern, A.; Sorek, R., Holding a grudge: persisting anti‐phage CRISPR immunity in multiple human gut microbiomes. RNA Biol. 2013, 10, 900–906.
98. Edgar, R.; Qimron, U. The Escherichia coli CRISPR system protects from lambda lysogenization, lysogens, and prophage induction. J. Bacteriol. 2010, 192, 6291–6294.
99. Bondy-Denomy, J.; Pawluk, A.; Maxwell, K.L.; Davidson, A.R. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 2013, 493, 429–432.
100. Duerkop, B.A.; Clements, C.V.; Rollins, D.; Rodrigues, J.L.; Hooper, L.V. A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc. Natl. Acad. Sci. USA 2012, 109, 17621–17626.
101. Reyes, A.; Wu, M.; McNulty, N.P.; Rohwer, F.L.; Gordon, J.I. Gnotobiotic mouse model of phage‐bacterial host dynamics in the human gut. Proc. Natl. Acad. Sci. USA 2013, 110, 20236–20241.
102. Maura, D.; Morello, E.; du Merle, L.; Bomme, P.; Le Bouguenec, C.; Debarbieux, L. Intestinal colonization by enteroaggregative Escherichia coli supports long‐term bacteriophage replication in mice. Environ. Microbiol. 2012, 14, 1844–1854.
103. Santiago-Rodriguez, T.M.; Ly, M.; Daigneault, M.C.; Brown, I.H.; McDonald, J.A.; Bonilla, N.; Vercoe, E.A.; Pride, D.T. Chemostat culture systems support diverse bacteriophage communities from human feces. Microbiome 2015, 3, 58.
104. Barr, J.J.; Auro, R.; Sam-Soon, N.; Kassegne, S.; Peters, G.; Bonilla, N.; Hatay, M.; Mourtada, S.; Bailey, B.; Youle, M., et al. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters. Proc. Natl. Acad. Sci. USA 2015, 112, 13675–13680.
105. Kim, H.J.; Li, H.; Collins, J.J.; Ingber, D.E. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut‐on‐a‐chip. Proc. Natl. Acad. Sci. USA 2016, 113, E7–E15.
106. McDonald, J.A.; Fuentes, S.; Schroeter, K.; Heikamp-de Jong, I.; Khursigara, C.M.; de Vos, W.M.; Allen-Vercoe, E. Simulating distal gut mucosal and luminal communities using packed‐column biofilm reactors and an in vitro chemostat model. J. Microbiol. Methods 2015, 108, 36–44.
107. Edwards, R.A.; McNair, K.; Faust, K.; Raes, J.; Dutilh, B.E. Computational approaches to predict bacteriophage‐host relationships. FEMS Microbiol. Rev. 2016, 40, 258–272.
108. Marbouty, M.; Baudry, L.; Cournac, A.; Koszul, R. Scaffolding bacterial genomes and probing host‐virus interactions in gut microbiome by proximity ligation (chromosome capture) assay. Sci. Adv. 2017, 3, e1602105.
109. Kilic, A.O.; Pavlova, S.I.; Alpay, S.; Kilic, S.S.; Tao, L. Comparative study of vaginal Lactobacillus phages isolated from women in the United States and Turkey: prevalence, morphology, host range, and DNA homology. Clin. Diagn. Lab. Immunol. 2001, 8, 31–39.
110. Howe, A.; Ringus, D.L.; Williams, R.J.; Choo, Z.N.; Greenwald, S.M.; Owens, S.M.; Coleman, M.L.; Meyer, F.; Chang, E.B. Divergent responses of viral and bacterial communities in the gut microbiome to dietary disturbances in mice. ISME J. 2016, 10, 1217–1227.
111. Francino, M.P. Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Front. Microbiol. 2015, 6, 1543.
112. Abeles, S.R.; Ly, M.; Santiago-Rodriguez, T.M.; Pride, D.T. Effects of Long Term Antibiotic Therapy on Human Oral and Fecal Viromes. PLoS One 2015, 10, e0134941.
113. Sun, C.L.; Relman, D.A. Microbiota’s ‘little helpers’: bacteriophages and antibiotic‐associated responses in the gut microbiome. Genome Biol. 2013, 14, 127.
114. Bojanova, D.P.; Bordenstein, S.R. Fecal Transplants: What Is Being Transferred? PLoS Biol. 2016, 14, e1002503.
115. Groen, A.K.; Nieuwdorp, M. An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases. EMBO Mol. Med. 2017, 9, 1–3.
116. Fuentes, S.; van Nood, E.; Tims, S.; Heikamp‐de Jong I.; ter Braak, C.J.; Keller, J.J.; Zoetendal, E.G.; de Vos, W.M. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J. 2014, 8, 1621–1633.
117. van Nood, E.; Vrieze, A.; Nieuwdorp, M.; Fuentes, S.; Zoetendal, E.G.; de Vos, W.M.; Visser, C.E.; Kuijper, E.J.; Bartelsman, J.F.; Tijssen, J.G., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 2013, 368, 407–415.
118. Moelling, K.; Broecker, F. Fecal microbiota transplantation to fight Clostridium difficile infections and other intestinal diseases. Bacteriophage 2016, 6, e1251380.
119. Gupta, S.; Allen-Vercoe, E., Petrof, E.O. Fecal microbiota transplantation: in perspective. Therap. Adv. Gastroenterol. 2016, 9, 229–239.
120. Andrews, P.J.; Borody, T.J. “Putting back the bugs”: bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome. Med. J. Aust. 1993, 159, 633–634.
121. Li, S.S.; Zhu, A.; Benes, V.; Costea, P.I.; Hercog, R.; Hildebrand, F.; Huerta-Cepas, J.; Nieuwdorp, M.; Salojarvi, J.; Voigt, A.Y.; et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 2016, 352, 586–589.
122. Vrieze, A.; Van Nood, E.; Holleman, F.; Salojarvi, J.; Kootte, R.S.; Bartelsman, J.F.; Dallinga-Thie, G.M.; Ackermans, M.T.; Serlie, M.J.; Oozeer, R.; et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143, 913–916e7.
123. Broecker, F.; Klumpp, J.; Moelling, K. Long‐term microbiota and virome in a Zurich patient after fecal transplantation against Clostridium difficile infection. Ann. N. Y. Acad. Sci. 2016, 1372, 29–41.
124. Broecker, F.; Klumpp, J.; Schuppler, M.; Russo, G.; Biedermann, L.; Hombach, M.; Rogler, G.; Moelling, K. Long‐term changes of bacterial and viral compositions in the intestine of a recovered Clostridium difficile patient after fecal microbiota transplantation. Cold Spring Harb. Mol. Case Stud. 2016, 2, a000448.
125. Broecker, F.; Kube, M.; Klumpp, J.; Schuppler, M.; Biedermann, L.; Hecht, J.; Hombach, M.; Keller, P.M.; Rogler, G.; Moelling, K. Analysis of the intestinal microbiome of a recovered Clostridium difficile patient after fecal transplantation. Digestion 2013, 88, 243–251.
126. Chehoud, C.; Dryga, A.; Hwang, Y.; Nagy-Szakal, D.; Hollister, E.B.; Luna, R.A.; Versalovic, J.; Kellermayer, R.; Bushman, F.D. Transfer of Viral Communities between Human Individuals during Fecal Microbiota Transplantation. MBio 2016, 7, e00322.
127. Bahra, S.M.; Weidemann, B.J.; Castro, A.N.; Walsh, J.W.; deLeon, O.; Burnett, C.M.; Pearson, N.A.; Murry, D.J.; Grobe, J.L.; Kirby, J.R. Risperidone‐induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine 2015, 2, 1725–1734.
128. Ott, S.J.; Waetzig, G.H.; Rehman, A.; Moltzau-Anderson, J.; Bharti, R.; Grasis, J.A.; Cassidy, L.; Tholey, A.; Fickenscher, H.; Seegert, D.; et al. Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. Gastroenterology 2017, 152, 799–811e7.
129. Koskella, B.; Parr, N. The evolution of bacterial resistance against bacteriophages in the horse chestnut phyllosphere is general across both space and time. Philos. Trans. R. Soc. Lond. B. 2015, 370. doi:10.1098/rstb.2014.0297.
130. Petrof, E.O.; Gloor, G.B.; Vanner, S.J.; Weese, S.J.; Carter, D.; Daigneault, M.C.; Brown, E.M.; Schroeter, K.; Allen-Vercoe, E. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut. Microbiome 2013, 1, 3.